Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Obinutuzumab
lenalidomide
+1 more
Locations
1
United States
University of California, San Diego
La Jolla, California, United States
Start Date
December 20, 2017
Primary Completion Date
May 2, 2022
Completion Date
May 2, 2022
Last Updated
July 5, 2022
NCT06846671
NCT07523555
NCT07030400
NCT06859424
NCT05589896
NCT06043011
Lead Sponsor
University of California, San Diego
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions